Testing

Antivirogram Test Proves Effective for Less-Prevalent HIV Strains

Published in AIDS Weekly, July 31st, 2000

Data presented at the 13th International Conference on AIDS, held in Durban, South Africa, July 9-14, 2000, from Virco's Antivirogram resistance test indicate that a second generation of HIV drugs may be highly active against the strains of HIV found in developing countries.

The phenotypic test used in the study (Antivirogram) is the only one to have been proven against all the subtypes of HIV, which predominate in developing countries in Africa and elsewhere.

The test was chosen to profile drugs from a second generation of non-nucleoside reverse transcriptase inhibitors (NNRTIs), being developed by DuPont Pharmaceuticals. First generation NNRTIs...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2000-07-31)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry